1 / 6

Pharmacovigilance Convention Centre, Symbiosis Lavale Campus, Pune

Pharmacovigilance Convention Centre, Symbiosis Lavale Campus, Pune. Name of the Speaker: Dr. Milind Sardesai Designation: Assistant Director, Lupin Pharmaceuticals Limited Topic : Pharmacovigilance. SUMMARY. Sir started with the definition of Pharmacovigilance .

winona
Download Presentation

Pharmacovigilance Convention Centre, Symbiosis Lavale Campus, Pune

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Convention Centre, Symbiosis Lavale Campus, Pune

  2. Name of the Speaker:Dr. MilindSardesai Designation: Assistant Director, Lupin Pharmaceuticals Limited Topic :Pharmacovigilance

  3. SUMMARY • Sir started with the definition of Pharmacovigilance. • Pharmacovigilance is a science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug related problems.

  4. Pharmacovigilance Aims : • Early detection • Detection of increase in frequency • Identification of risk factors • Quantifying risks • Preventing patients from being affected unnecessarily PV activities Case processing & aggregate reporting Signal detection & risk management

  5. Integrated approach in Pharmacovigilance • Pre-marketing risk assessment • Integrated safety • Approval • Post marketing safety assessment • Re-assess & modify • New safety information SOP in ethics committee Informed consent & safety reports Protocol development & clinical trial documentation

  6. Report Prepared By: • AkhilaNayak • Anisha Mehta • Ebrahim Khan • Nikhil Dhorepatil • Shirin Khan • Swati Sonik • YogitaPatil (MBA –HHM 2013-15)

More Related